PP inhibits hypothalamic release of neuropeptides that stimulate eating, enhances release of anorexigenic hypothalamic peptides, and suppresses gastric release of ghrelin (an appetite stimulant) (Asakawa et al., 2003), with potentially beneficial effects in diabetics. Here, GHRL is linked to diabetes mellitus.